Efficacy and safety of cardiac resynchronization therapy in chemotherapy-induced cardiomyopathy: A systematic review

被引：0
|
作者：
Shehram, Muhammad [1 ]
Khalid, Hiba [2 ]
Shafique, Hafiz Muhammad [3 ]
Umer, Bakht [3 ]
Zafar, Awais [4 ]
Ullah, Asif [5 ]
Zaidi, Syed Muhammad Jawad [6 ]
Basit, Jawad [6 ]
Mehmoodi, Amin [7 ]
Malik, Jahanzeb [6 ]
机构：
[1] Mufti Mehmood Mem Teaching Hosp, Dept Cardiol, Dera Ismail Khan, Pakistan
[2] Benazir Bhutto Hosp, Dept Dermatol, Rawalpindi, Pakistan
[3] Armed Forces Inst Cardiol, Dept Intervent Cardiol, Rawalpindi, Pakistan
[4] Sahiwal Med Coll, Dept Med, Sahiwal, Pakistan
[5] Khyber Med Univ, Inst Med Sci, Dept Cardiol, Kohat, Pakistan
[6] Cardiovasc Analyt Grp, Dept Cardiovasc Med, Canterbury, England
[7] Ibn e Seen Hosp, Dept Med, Kabul, Afghanistan
来源：
ANNALS OF NONINVASIVE ELECTROCARDIOLOGY | 2023年 / 28卷 / 05期
关键词：
anthracycline; diastolic dysfunction; ejection fraction; heart failure; HEART-FAILURE; CARDIOTOXICITY; PREVENTION;
D O I：
10.1111/anec.13070
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
ObjectiveThe aim of the study was to assess the efficacy of cardiac resynchronization therapy (CRT) in patients with chemotherapy-induced cardiomyopathy (CIC). MethodsWith the increasing incidence of CIC, the association of CRT with improvement in clinical outcomes, echocardiographic parameters, and New York Heart Classification (NYHA) class was assessed through this qualitative systematic review. ResultsThe five studies included a total of 169 patients who underwent CRT after CIC, and of these, 61 (36.1%) patients were males. All studies showed an improvement in left ventricular ejection fraction (LVEF), among other echocardiographic parameters of LV volume. However, these findings are limited by short follow-up periods, small sample sizes, and the absence of a control group. ConclusionCRT was associated with improvement in all patient parameters with CIC.
引用
收藏
页数：6
相关论文
共 50 条
  • [1] Outcomes of cardiac resynchronization therapy in patients with chemotherapy-induced cardiomyopathy
    Ezzeddine, Fatima M.
    Saliba, Antoine N.
    Jain, Vaibhav
    Villarraga, Hector R.
    Herrmann, Joerg
    Asirvatham, Samuel J.
    Cha, Yong-Mei
    PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY, 2021, 44 (04): : 625 - 632
  • [2] Association of Cardiac Resynchronization Therapy With Change in Left Ventricular Ejection Fraction in Patients With Chemotherapy-Induced Cardiomyopathy
    Singh, Jagmeet P.
    Solomon, Scott D.
    Fradley, Michael G.
    Barac, Ana
    Kremer, Kristina A.
    Beck, Christopher A.
    Brown, Mary W.
    McNitt, Scott
    Schleede, Susan
    Zareba, Wojciech
    Goldenberg, Ilan
    Kutyifa, Valentina
    Montgomery, Jay
    Gordon, Mary
    Langan, Marie-Noelle
    Harcum, Stephanie
    Alexander, Nebu
    Celkupa, Didjana
    Fradley, Michael
    Nhi Tran
    Storozynsky, Eugene
    Wing, Laura
    Rosner, Gregg
    O'Connor, Daniel
    Gonzales, Paul
    Karimzad, Kaveh
    Gachimova, Evguenia
    Oliveira, Guilherme
    Norton, Nadine
    Nohria, Anju
    Anello, Mary
    Krone, Ronald
    Faddis, Mitchell
    Amsler, Janice
    Yang, Eric
    Sorg, Julie
    Goldstein, Robert
    Oakes, David
    Haigney, Mark
    Solomon, Scott David
    Beck, Christopher
    Kremer, Kristina
    Impellizzeri, Audrey
    Moss, Arthur J.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2019, 322 (18): : 1799 - 1805
  • [3] Efficacy of cardiac resynchronization therapy in patients with isolated ventricular noncompaction with dilated cardiomyopathy: a systematic review of the literature
    Bertini, Matteo
    Balla, Cristina
    Pavasini, Rita
    Boriani, Giuseppe
    JOURNAL OF CARDIOVASCULAR MEDICINE, 2018, 19 (07) : 324 - 328
  • [4] Chemotherapy-induced cardiomyopathy
    Angela Y. Higgins
    Thomas D. O’Halloran
    James D. Chang
    Heart Failure Reviews, 2015, 20 : 721 - 730
  • [5] Chemotherapy-induced cardiomyopathy
    Higgins, Angela Y.
    O'Halloran, Thomas D.
    Chang, James D.
    HEART FAILURE REVIEWS, 2015, 20 (06) : 721 - 730
  • [6] Anthracycline-induced cardiomyopathy: Favourable effects of cardiac resynchronization therapy
    Ahlehoff, Ole
    Galloe, Anders M.
    Hansen, Peter R.
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2010, 142 (02) : E23 - E24
  • [7] Anthracycline Chemotherapy-Induced Cardiotoxicity in Breast Cancer Survivors: A Systematic Review
    Lin, Katherine Jinghua
    Lengacher, Cecile A.
    ONCOLOGY NURSING FORUM, 2019, 46 (05) : E145 - E158
  • [8] Efficacy, tolerability, and safety of cannabinoids for chemotherapy-induced nausea and vomiting-a systematic review of systematic reviews
    Tafelski, S.
    Haeuser, W.
    Schaefer, M.
    SCHMERZ, 2016, 30 (01): : 14 - 24
  • [9] Efficacy of optimal medical therapy and cardiac resynchronization therapy upgrade in patients with pacemaker-induced cardiomyopathy
    Schwerg, Marius
    Dreger, Henryk
    Poller, Wolfram C.
    Dust, Benjamin
    Melzer, Christoph
    JOURNAL OF INTERVENTIONAL CARDIAC ELECTROPHYSIOLOGY, 2015, 44 (03) : 289 - 296
  • [10] Efficacy of optimal medical therapy and cardiac resynchronization therapy upgrade in patients with pacemaker-induced cardiomyopathy
    Marius Schwerg
    Henryk Dreger
    Wolfram C. Poller
    Benjamin Dust
    Christoph Melzer
    Journal of Interventional Cardiac Electrophysiology, 2015, 44 : 289 - 296
12345